This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergmann, O J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergmann, O J

 Previous Article  |  Next Article 

J Clin Microbiol. 1988 October; 26(10): 2105-2109

Oral infections and septicemia in immunocompromised patients with hematologic malignancies.

O J Bergmann

University Department of Medicine and Hematology, Aarhus County Hospital, Denmark.

ABSTRACT

To estimate the role of oral infections during septicemic episodes in immunocompromised patients with hematologic malignancies, 78 febrile episodes in 46 patients were monitored with daily clinical and microbiological investigations. The 19 septicemic episodes did not differ from the 59 other febrile episodes in the qualitative composition of the aerobic and facultatively anaerobic oral microflora or in the presence of teeth or acute oral infections on day 1. The oral prevalence rates of members of the family Enterobacteriaceae were higher on days 10, 11, and 12 in the febrile episodes with septicemia when compared with those of febrile episodes without septicemia. The prevalence of a probable oral focus in septicemia was 10.5%, and the prevalence of a probable or possible oral origin in septicemia was 31.6%. The results suggest that prevention and elimination of oral infections may reduce the morbidity and perhaps even the mortality in these patients.


J Clin Microbiol. 1988 October; 26(10): 2105-2109




This article has been cited by other articles:

  • SMITH, A.J., JACKSON, M.S., BAGG, J. (2001). The ecology of Staphylococcus species in the oral cavity. J Med Microbiol 50: 940-946 [Abstract] [Full Text]  
  • Kostler, W. J., Hejna, M., Wenzel, C., Zielinski, C. C. (2001). Oral Mucositis Complicating Chemotherapy and/or Radiotherapy: Options for Prevention and Treatment. CA Cancer J Clin 51: 290-315 [Abstract] [Full Text]  
  • Mosca, D. A., Hurst, M. A., So, W., Viajar, B. S. C., Fujii, C. A., Falla, T. J. (2000). IB-367, a Protegrin Peptide with In Vitro and In Vivo Activities against the Microflora Associated with Oral Mucositis. Antimicrob. Agents Chemother. 44: 1803-1808 [Abstract] [Full Text]  
  • Meurman, J.H., Pajukoski, H., Snellman, S., Zeiler, S., Sulkava, R. (1997). Oral Infections in Home-living Elderly Patients Admitted to an Acute Geriatric Ward. JDR 76: 1271-1276 [Abstract]  
  • Bergmann, O. J, Ellermann-Eriksen, S., Mogensen, S. C, Ellegaard, J. (1995). Acyclovir given as prophylaxis against oral ulcers in acute myeloid leukaemia: randomised, double blind, placebo controlled trial. BMJ 310: 1169-1172 [Abstract] [Full Text]  
  • Brown, A.T., Sims, R.E., Raybould, T.P., Lillich, T.T., Henslee, P.J., Ferretti, G.A. (1989). Oral Gram-negative Bacilli in Bone Marrow Transplant Patients Given Chlorhexidine Rinses. JDR 68: 1199-1204 [Abstract]